| Mary Morgan Kaufman, PT | |
|
2311 S Kansas Rd, Newton, KS 67114-9032 | |
| (316) 669-1648 | |
| (316) 803-1516 |
| Full Name | Mary Morgan Kaufman |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 11 Years |
| Location | 2311 S Kansas Rd, Newton, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245679414 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 11-04647 (Kansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Pt Of Newton, Llc | 3476616848 | 10 |
News Archive
A new trial has found that pneumococcal vaccine is effective in preventing severe pneumonia, the leading cause of death among children in developing countries. Co-ordinated by the National Institute for Health and Welfare (THL) between 2000 and 2004, a large scale efficacy trial - first of its kind in Asia - was carried out in the Philippines to investigate the effect of an investigational pneumococcal vaccine.
The prevalence of gout-a form of arthritis characterized by severe pain, redness, and tenderness in joints-increased across the world at an alarming rate from 1990 to 2017, according to an analysis published in Arthritis & Rheumatology.
Amgen Inc. today announced the publication of results from the first open-label study to compare Nplate® (romiplostim) treatment to standard of care therapies (SOC) in non-splenectomized adult patients with chronic immune thrombocytopenia (ITP). The study results, which were published today in the New England Journal of Medicine (NEJM), show that both the incidence of treatment failure and need for splenectomy were reduced among the Nplate-treated patients.
Tenofovir gel, a vaginal microbicide that has shown promise for preventing HIV through vaginal sex, is being tested in a new trial looking at its safety and acceptability when used rectally. The results of the study, being led by the U.S. National Institutes of Health (NIH)-funded Microbicide Trials Network (MTN), will help determine if the gel should be evaluated further for its potential to prevent HIV among both men and women who engage in receptive anal intercourse.
› Verified 7 days ago
| Provider Name | Advanced Pt Of Newton, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1801043369 PECOS PAC ID: 3476616848 Enrollment ID: O20090112000176 |
News Archive
A new trial has found that pneumococcal vaccine is effective in preventing severe pneumonia, the leading cause of death among children in developing countries. Co-ordinated by the National Institute for Health and Welfare (THL) between 2000 and 2004, a large scale efficacy trial - first of its kind in Asia - was carried out in the Philippines to investigate the effect of an investigational pneumococcal vaccine.
The prevalence of gout-a form of arthritis characterized by severe pain, redness, and tenderness in joints-increased across the world at an alarming rate from 1990 to 2017, according to an analysis published in Arthritis & Rheumatology.
Amgen Inc. today announced the publication of results from the first open-label study to compare Nplate® (romiplostim) treatment to standard of care therapies (SOC) in non-splenectomized adult patients with chronic immune thrombocytopenia (ITP). The study results, which were published today in the New England Journal of Medicine (NEJM), show that both the incidence of treatment failure and need for splenectomy were reduced among the Nplate-treated patients.
Tenofovir gel, a vaginal microbicide that has shown promise for preventing HIV through vaginal sex, is being tested in a new trial looking at its safety and acceptability when used rectally. The results of the study, being led by the U.S. National Institutes of Health (NIH)-funded Microbicide Trials Network (MTN), will help determine if the gel should be evaluated further for its potential to prevent HIV among both men and women who engage in receptive anal intercourse.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary Morgan Kaufman, PT 10400 W 103rd St, Suite 22, Overland Park, KS 66214-2640 Ph: (913) 322-4000 | Mary Morgan Kaufman, PT 2311 S Kansas Rd, Newton, KS 67114-9032 Ph: (316) 669-1648 |
News Archive
A new trial has found that pneumococcal vaccine is effective in preventing severe pneumonia, the leading cause of death among children in developing countries. Co-ordinated by the National Institute for Health and Welfare (THL) between 2000 and 2004, a large scale efficacy trial - first of its kind in Asia - was carried out in the Philippines to investigate the effect of an investigational pneumococcal vaccine.
The prevalence of gout-a form of arthritis characterized by severe pain, redness, and tenderness in joints-increased across the world at an alarming rate from 1990 to 2017, according to an analysis published in Arthritis & Rheumatology.
Amgen Inc. today announced the publication of results from the first open-label study to compare Nplate® (romiplostim) treatment to standard of care therapies (SOC) in non-splenectomized adult patients with chronic immune thrombocytopenia (ITP). The study results, which were published today in the New England Journal of Medicine (NEJM), show that both the incidence of treatment failure and need for splenectomy were reduced among the Nplate-treated patients.
Tenofovir gel, a vaginal microbicide that has shown promise for preventing HIV through vaginal sex, is being tested in a new trial looking at its safety and acceptability when used rectally. The results of the study, being led by the U.S. National Institutes of Health (NIH)-funded Microbicide Trials Network (MTN), will help determine if the gel should be evaluated further for its potential to prevent HIV among both men and women who engage in receptive anal intercourse.
› Verified 7 days ago
Peggy Brown, PTA Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2311 S Kansas Rd, Newton, KS 67114 Phone: 316-283-7187 Fax: 316-283-7189 | |
David Kempin, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2311 S Kansas Rd, Newton, KS 67114 Phone: 316-282-3041 Fax: 316-282-3042 | |
Mr. Matt Downey, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 600 Medical Center Dr, Newton, KS 67114 Phone: 316-804-6080 | |
Mr. Scott Bradley Fieser, P.T., CSCS Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2311 S Kansas Rd, Newton, KS 67114 Phone: 316-283-7187 Fax: 316-283-7189 | |
Christopher Andres De Jesus, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Sw 14th St, Newton, KS 67114 Phone: 321-316-7085 | |
Eugene Housdon, PTA Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2311 S Kansas Rd, Newton, KS 67114 Phone: 316-283-7187 | |
Mr. Jeff C Couchman, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 600 Medical Center Dr, Newton, KS 67114 Phone: 316-804-6087 Fax: 316-804-6265 |